Peng Zhang

Peng Zhang is an accomplished professional with extensive experience in the fields of finance, artificial intelligence, and pharmaceuticals. Currently serving as Chief Financial Officer at Imperial Dermatology since October 2020, Peng previously held the position of Associate Director for AI Solution Delivery at IQVIA NLP from April 2019 to July 2024. Prior experience includes a significant tenure as Senior Staff Scientist in the Target Information Group at Regeneron Pharmaceuticals from September 2010 to March 2019, and roles as Research Scientist in Early Target Biology and Scientist I in BioDiscovery at Lundbeck Research USA between February 2006 and September 2010. Peng holds a Ph.D. in Pharmacology/Bioinformatics from Rutgers University and a B.S. in Biochemistry from Nanjing University.